Precipio Granted 180-day Extension From NASDAQ To Regain Compliance
NEW HAVEN, Conn., April 27, 2023 (GLOBE NEWSWIRE) — Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces notification by the NASDAQ Stock Market that the Company has been granted a 180-day extension to allow the Company to meet the required minimum $1.00 per share closing bid price of its common stock for 10 consecutive business days for continued inclusion on the Nasdaq Capital Market Exchange.
Related news for (PRPO)
- Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting
- Precipio Announces Q1-2025 Shareholder Update Call
- Precipio Announces Q4 and year-end 2024 Shareholder Update Call
- Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited)
- Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs